SPEAR MATTHEW A. (Chief Medical Officer) sold 19.5% of their position (4K shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $37.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/14/2021ACC: 0001209191-21-040324
Officer· Chief Medical Officer
Since Jul 2020
-4K
Net shares
Net seller
$37.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4K acquired · 8K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4K
Price / share
$1.32
Trade value
$5.29K
% of position
24.3%
6/11/2021
16.48K→20.48K
Common Stock
Direct
Shares
−4K
Price / share
$9.44
Trade value
$37.75K
% of position
19.5%
6/11/2021
20.48K→16.48K
Total
Net shares
+0.00
Net value
-$32.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2021 | M · Option Exercise | +4K | $1.32 | $5.29K | 24.3% | 16.48K | 20.48K |
| Common Stock Direct | 6/11/2021 | S · Sale | −4K | $9.44 | $37.75K | 19.5% | 20.48K | 16.48K |
| Total | +0.00 | -$32.46K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4K shares
Shares
−4K
Strike price
1.322
Held after
119.86K
Exercisable
—
6/11/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4K shares | 6/11/2021 | M · Option Exercise | −4K | 1.322 | — | 119.86K |